AKT1 and hepatocellular carcinoma: However, EpCAM+ HCC1 and Huh7 cells as well as CD90+ HCC-derived SK-HEP1 cells rapidly developed resistance against the combined treatment with AKT and mTOR inhibitors in orthotopic liver cancer models in mice.